The editor-in-chief of MC has many articles written by Chinese people praising him for his attention to detail.

(0) 讚！ | 铁头令燕

When did the University ever blacklist any journal? There are all kinds of rumors online.

(0) 讚！ | 淡@忘

I really don't understand how this article got published. It's hard to imagine that anyone would give it a 5-star rating with such little content. How did they manage to do it?

(0) 讚！ | 魔都吉星

Many circRNAs have no lower limit.

(0) 讚！ | 铁头令燕

Please translate the following passage into English: slowly

(0) 讚！ | 铁头令燕

Hmm

(0) 讚！ | 铁头令燕

The CircLIFRSA/miR-1305/PTEN axis attenuates malignant cellular processes in non-small cell lung cancer by regulating AKT phosphorylation. This article has an actual level of 3-5 points. It is based on a single cell line experiment, with no in vivo experiments, and is a research-oriented article.

(0) 讚！ | 铁头令燕

Yes, however, I did come across two very superficial articles on non-coding RNA recently.

(0) 讚！ | Lucy Larkin

Can you help me post a piece of content that is 3-5 minutes long? I will give you the content and an additional 100,000 RMB.

(0) 讚！ | 魔都吉星

It doesn't feel bad, the data volume is there, and the mechanisms are also quite comprehensive, including for noncoding regions, I don't see any obvious deficiencies.

(0) 讚！ | 魔都吉星

Yes.

(0) 讚！ | 魔都吉星

But Zhongshan doesn't have a blacklist... There is a junior student working in Zhongshan, he said they don't have it, and I don't know where it came from...

(0) 讚！ | 魔都吉星

Review speed: 2.0 | Submission hit rate: 25.0 Emphasis on research direction: Tumor microenvironment; Tumor experience sharing: Recently submitted two reviews, one was rejected instantly (in about 2 days), and one was sent for external review. Three reviewers provided more than 40 suggestions. After carefully revising according to the opinions, it was quickly accepted. The whole process took a little over two months, which was considered very smooth. Submitting reviews is still quite difficult, and the topic and quality of the article should be favored by the editors to have a chance.

(0) 讚！ | 英韶酱吖

The journal Molecular Cancer gains a lot of impact by publishing reviews, etc. However, when calculating the immediate factor of its pure research series articles, it still exceeds 10 points. It is definitely not a journal that can be dismissed as mediocre.

(0) 讚！ | Lucy Larkin

Zhongshan did not blacklist, nor did it give any warnings.

(0) 讚！ | 魔都吉星

After carefully reading articles from the past 23 years up until now, I don't think they are as mediocre as they claimed. The quality is not bad at all.

(0) 讚！ | 魔都吉星

What are you thinking about the other school?

(0) 讚！ | 海莹Sama

About two weeks

(0) 讚！ | 英韶酱吖

How long after acceptance will it be published?

(0) 讚！ | 北冥俊远

How long after you received it did your article get published, boss?

(0) 讚！ | 北冥俊远

Acceptance of submissions follows the submission guidelines and formatting requirements.

(0) 讚！ | Adelaide Lawson

Since both Big CDD and Molecular Cancer can be submitted for review, we can also try Advanced Science, with high hopes.

(0) 讚！ | Lucy Larkin

Submitted a relatively large article with substantial data, not too cliché, but it was rejected by a top-tier journal after the first round of review. Sigh... it's never that easy.

(0) 讚！ | 魔都吉星

Best wishes.

(0) 讚！ | 宗室锐立

Research focus: Tumor Neurobiology
Experience sharing: Submitted a review article on July 1st, documenting the submission process here.

(0) 讚！ | 暗月寺天震